重组Anti-VANGL1抗体[EPR12415] (ab176575)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR12415] to VANGL1
- Suitable for: WB
- Reacts with: Human
Related conjugates and formulations
概述
-
产品名称
Anti-VANGL1抗体[EPR12415]
参阅全部 VANGL1 一抗 -
描述
兔单克隆抗体[EPR12415] to VANGL1 -
宿主
Rabbit -
经测试应用
适用于: WBmore details
不适用于: Flow Cyt,ICC/IF,IHC-P or IP -
种属反应性
与反应: Human
预测可用于: Mouse, Rat -
免疫原
Synthetic peptide within Human VANGL1 aa 200-300 (internal sequence) (Cysteine residue). The exact sequence is proprietary.
Database link: Q8TAA9 -
阳性对照
- MCF7, HeLa, Jurkat and MOLT4 cell lysates.
-
常规说明
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
存储溶液
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading...
-
纯度
Tissue culture supernatant -
克隆
单克隆 -
克隆编号
EPR12415 -
同种型
IgG -
研究领域
相关产品
-
Alternative Versions
-
Isotype control
-
Positive Controls
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab176575于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
WB |
1/1000 - 1/5000. Predicted molecular weight: 60 kDa.
|
说明 |
---|
WB
1/1000 - 1/5000. Predicted molecular weight: 60 kDa. |
靶标
-
组织特异性
Accordiing to PubMed:11956595, ubiquitously expressed. According to PubMed:12011995, expressed specifically in testis and ovary. -
疾病相关
Defects in VANGL1 are a cause of neural tube defects (NTD) [MIM:182940]. NTD are congenital malformations. The most common forms of NTD are described as open defects (including anencephaly and myelomeningocele, or spina bifida), which result from the failure of fusion in the cranial and spinal region of the neural tube, respectively. Other open dysraphisms (including myeloschisis, hemimyelomeningocele, and hemimyelocele) are sometimes associated with a Chiari type 2 malformation. A number of skin-covered (closed) NTD are categorized clinically depending on the presence of a subcutaneous mass (lipomyeloschisis, lipomyelomeningocele, meningocele, and myelocystocele) or the absence of such a mass (complex dysraphic states, including split cord malformations, dermal sinus, caudal regression, and segmental spinal dysgenesis).
Defects in VANGL1 are a cause of sacral defect with anterior meningocele (SDAM) [MIM:600145]. SDAM is a form of caudal dysgenesis. It is present at birth and becomes symptomatic later in life, usually because of obstructive labor in females, chronic constipation, or meningitis. Inheritance is autosomal dominant. -
序列相似性
Belongs to the Vang family. -
细胞定位
Membrane. - Information by UniProt
-
数据库链接
- Entrez Gene: 81839 Human
- Entrez Gene: 229658 Mouse
- Entrez Gene: 690366 Rat
- Omim: 610132 Human
- SwissProt: Q8TAA9 Human
- SwissProt: Q80Z96 Mouse
- Unigene: 515130 Human
- Unigene: 118004 Mouse
-
别名
- ANGL planar cell polarity protein 1 antibody
- KAI1 C-terminal interacting tetraspanin antibody
- KITENIN antibody
see all
图片
-
All lanes : Anti-VANGL1 antibody [EPR12415] (ab176575) at 1/1000 dilution
Lane 1 : MCF7 cell lysate
Lane 2 : HeLa cell lysate
Lane 3 : Jurkat cell lysate
Lane 4 : MOLT4 cell lysate
Lysates/proteins at 10 µg per lane.
Developed using the ECL technique.
Predicted band size: 60 kDa
数据表及文件
-
SDS download
-
Datasheet download
文献 (0)
ab176575 尚未被引用在任何文献中。